Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Valeant Offers to Buy Botox Maker Allergan With Pershing Support

Allergan Inc.’s Botox Wrinkle Treatment
Allergan Inc.’s Botox wrinkle treatment is arranged at a hospital in Boston. Photographer: JB Reed/Bloomberg

April 22 (Bloomberg) -- Valeant Pharmaceuticals International Inc. offered to buy Allergan Inc. for about $152.89 a share in a cash-and-stock deal that will give the Canadian company the Botox wrinkle treatment.

Allergan investors would receive $48.30 in cash and 0.83 percent of a Valeant share in the deal, Valeant said in a statement today. Pershing Square Management LP, Allergan’s largest shareholder with 9.7 percent of shares outstanding, supports the purchase, Valeant said. The per-share value of the offer is based on yesterday’s closing price.

Link to Statement:{NSN N4FJYB3MSFLS <GO>}

Link to Company News:{AGN US <Equity> CN <GO>} Link to Company News:{VRX CN <Equity> CN <GO>}

To contact the editor responsible for this story: Bruce Rule at brule1@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.